NDC properties for "adalimumab-aaty 80 MG per 0.8 ML Auto-Injector" (RxCUI 2668487)
About this data
The tables show NDC propoerties for adalimumab-aaty 80 MG per 0.8 ML Auto-Injector with the RxCUI 2668487
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-aaty 80 MG per 0.8 ML Auto-Injector (RxCUI 2668487)
| BLA | BLA761219 |
|---|---|
| MMSL_CODE | BD40241 |
| RxCUI | 2668487 |
| SPL_SET_ID | c44365e9-d470-4e35-978d-8565a9e3471e |
| VUID | 4042781 |
| Prescribable Synonym | adalimumab-aaty 80 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML adalimumab-aaty 100 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-aaty 100 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-aaty 80 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2668487) |
NDC Properties
NDC Item 72606004004
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-04 |
| NDC Item | 72606004004 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-04) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 850496 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004005
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-05 |
| NDC Item | 72606004005 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-040-05) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 850496 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004004
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-04 |
| NDC Item | 72606004004 |
| Packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-04) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 850496 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |
NDC Item 72606004005
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-05 |
| NDC Item | 72606004005 |
| Packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-040-05) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 850496 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-040 |